Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Phenylketonuria (PKU) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.
This report presents the market size and development trends by detailing the Phenylketonuria (PKU) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Phenylketonuria (PKU) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Phenylketonuria (PKU) industry and will help you to build a panoramic view of the industrial development.
Phenylketonuria (PKU) Market, By Type:
Drug therapy
Dietary therapy
Gene therapy
Phenylketonuria (PKU) Market, By Application:
Hospital Pharmacies
Drug Stores
Online Pharmacies
Pediatric Clinics
Some of the leading players are as follows:
Synthetic Biologics
Daiichi Sankyo Company
SOM Innovation Biotech SL.
Dimension Therapeutics
Codexis, Inc
Erytech Pharma SA
American Gene Technologies International
BioMarin Pharmaceutical
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Phenylketonuria (PKU) Market: Technology Type Analysis
-
4.1 Phenylketonuria (PKU) Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Phenylketonuria (PKU) Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Drug therapy
4.3.2 Dietary therapy
4.3.3 Gene therapy
5 Phenylketonuria (PKU) Market: Product Analysis
-
5.1 Phenylketonuria (PKU) Product Market Share Analysis, 2018 & 2026
-
5.2 Phenylketonuria (PKU) Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Phenylketonuria (PKU) Market: Application Analysis
-
6.1 Phenylketonuria (PKU) Application Market Share Analysis, 2018 & 2026
-
6.2 Phenylketonuria (PKU) Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Pharmacies
6.3.2 Drug Stores
6.3.3 Online Pharmacies
6.3.4 Pediatric Clinics
7 Phenylketonuria (PKU) Market: Regional Analysis
-
7.1 Phenylketonuria (PKU) Regional Market Share Analysis, 2018 & 2026
-
7.2 Phenylketonuria (PKU) Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Synthetic Biologics
9.1.1 Synthetic Biologics Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Daiichi Sankyo Company
9.2.1 Daiichi Sankyo Company Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 SOM Innovation Biotech SL.
9.3.1 SOM Innovation Biotech SL. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Dimension Therapeutics
9.4.1 Dimension Therapeutics Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Codexis, Inc
9.5.1 Codexis, Inc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Erytech Pharma SA
9.6.1 Erytech Pharma SA Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 American Gene Technologies International
9.7.1 American Gene Technologies International Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 BioMarin Pharmaceutical
9.8.1 BioMarin Pharmaceutical Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
The List of Tables and Figures (Totals 104 Figures and 132 Tables)
Figure Drug therapy Phenylketonuria (PKU) market, 2015 - 2026 (USD Million)
Figure Dietary therapy Phenylketonuria (PKU) market, 2015 - 2026 (USD Million)
Figure Gene therapy Phenylketonuria (PKU) market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)
Figure Drug Stores market, 2015 - 2026 (USD Million)
Figure Online Pharmacies market, 2015 - 2026 (USD Million)
Figure Pediatric Clinics market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Phenylketonuria (PKU) market, by country, 2015 - 2026 (USD Million)
-
Table North America Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table North America Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table North America Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Canada Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Canada Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Europe Phenylketonuria (PKU) market, by country, 2015 - 2026 (USD Million)
-
Table Europe Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Europe Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Europe Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Germany Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Germany Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table France Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table France Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Italy Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Italy Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Spain Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Spain Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Phenylketonuria (PKU) market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table China Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table China Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Japan Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Japan Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table India Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table India Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Phenylketonuria (PKU) market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table MEA Phenylketonuria (PKU) market, by country, 2015 - 2026 (USD Million)
-
Table MEA Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table MEA Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table MEA Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Phenylketonuria (PKU) market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Phenylketonuria (PKU) market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Phenylketonuria (PKU) market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Synthetic Biologics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Daiichi Sankyo Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SOM Innovation Biotech SL. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dimension Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Codexis, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Erytech Pharma SA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table American Gene Technologies International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioMarin Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
